Quick Answer
LIXTE BIOTECHNOLOGY HOLDINGS, INC. reported Stockholders Equity of $9.66 million for the year ending 2025.
- LIXTE BIOTECHNOLOGY HOLDINGS, INC. showed an increase of +1,068.3% in Stockholders Equity from 2024 to 2025.
- This data is from LIXTE BIOTECHNOLOGY HOLDINGS, INC.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2014: $265.9 thousand | Q1 2015: $1.43 million | Q2 2015: $1.33 million | Q3 2015: $804.9 thousand | Q1 2016: $1.03 million | Q2 2016: $1.24 million | Q3 2016: $738.0 thousand | Q1 2017: $666.1 thousand | Q2 2017: $1.82 million | Q3 2017: $1.39 million | Q1 2018: $615.9 thousand | Q2 2018: $244.5 thousand | Q3 2018: -$14.1 thousand | Q1 2019: $3.71 million | Q2 2019: $3.40 million | Q3 2019: $2.76 million | Q1 2020: $2.05 million | Q2 2020: $1.68 million | Q3 2020: $1.14 million | Q1 2021: $7.65 million | Q2 2021: $6.87 million | Q3 2021: $6.07 million | Q1 2022: $3.47 million | Q2 2022: $7.49 million | Q3 2022: $6.41 million | Q1 2023: $4.08 million | Q2 2023: $2.69 million | Q3 2023: $4.92 million | Q4 2023: $3.99 million | Q1 2024: $3.13 million | Q2 2024: $2.25 million | Q3 2024: $1.37 million | Q1 2025: $1.16 million | Q2 2025: $651.5 thousand | Q3 2025: $4.91 million.
- Over the full 18 years of available data (2008 to 2025), LIXTE BIOTECHNOLOGY HOLDINGS, INC.'s Stockholders Equity has grown by 3,086.9%.
- Historical annual values: Fiscal year 2025: $9.66 million | Fiscal year 2024: $827.2 thousand | Fiscal year 2023: $3.99 million | Fiscal year 2022: $5.17 million | Fiscal year 2021: $4.79 million | Fiscal year 2020: $5.01 million | Fiscal year 2019: $2.43 million | Fiscal year 2018: $4.13 million | Fiscal year 2017: $995.0 thousand | Fiscal year 2016: $214.8 thousand | Fiscal year 2015: $312.3 thousand | Fiscal year 2014: $265.9 thousand | Fiscal year 2013: $236.3 thousand | Fiscal year 2012: $1.49 million | Fiscal year 2011: $79.0 thousand | Fiscal year 2010: $1.74 million | Fiscal year 2009: $1.30 million | Fiscal year 2008: -$323.5 thousand.
- Data sourced from SEC EDGAR public filings as of August 4, 2026.
Last verified: